01/29/2012

World Heart Federation

>

WorldHeartFederation

>

World Heart Federation,The site is contains information about rheumatic fever and rheumatic heart disease for Health Professionals and for Families and Communities. These are available free of charge and with the kind permission of their publishers.

Kenya Heart Foundation: RHD prevention programme receives Heart Hero Award >

View Dr.World Heart Federation Jonathan Carapetis television interview on Rheumatic Heart Disease >

The World Heart Federations website for rheumatic heart disease is an international resource developed primarily for clinicians, health practitioners and policy-makers in countries where the disease is still common. Its purpose is to promote rheumatic heart disease control through best practice including registration of people with disease and secondary prevention of rheumatic fever.

This section contains education& training materials, register databases,best-practiceguidelines& from programmes around the world.

Contact us&124;Site map&124;Impressum&124;Donate online&124;Terms and Conditions&124;©2012World Heart Federation

Research confirms that risk of developing rheumatic fever is influenced by inheritance >

View the NCD Alliance publication entitled: "A Focus on Children and Non-Communicable Diseases" >

This section contains links to inform and promote rheumatic heart disease awareness in the community.

Jan 29, 2012 2:23:19 AM

The comments to this entry are closed.

NEXT POST
hypertension treatment navailable hypertension treatment navailable, Please indicate whypertension treatment navailablehat information you were trying to access(e.g., what URL you were trying to access) when youreceived this message. If you typed in the URL that you tried to access,please check for typos since that can cause this error.We regret any inconvhypertension treatmentenience.
PREVIOUS POST
diabetes exercise U.S. FDA approves Amylins diabetes drug Taken once a week, Bydureon has been viewed as crucial to sustaining the franchise started by the twice-daily Byetta. Novo Nordisks Victoza, another injectable diabetes medicine, has had almost two extra years to gain traction with patients and doctors. The delays have also given time for potential rival treatments from...